UniProt ID | FHL2_HUMAN | |
---|---|---|
UniProt AC | Q14192 | |
Protein Name | Four and a half LIM domains protein 2 | |
Gene Name | FHL2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 279 | |
Subcellular Localization | Cytoplasm. Nucleus. Cytoplasm, myofibril, sarcomere, Z line . | |
Protein Description | May function as a molecular transmitter linking various signaling pathways to transcriptional regulation. Negatively regulates the transcriptional repressor E4F1 and may function in cell growth. Inhibits the transcriptional activity of FOXO1 and its apoptotic function by enhancing the interaction of FOXO1 with SIRT1 and FOXO1 deacetylation. Negatively regulates the calcineurin/NFAT signaling pathway in cardiomyocytes. [PubMed: 28717008] | |
Protein Sequence | MTERFDCHHCNESLFGKKYILREESPYCVVCFETLFANTCEECGKPIGCDCKDLSYKDRHWHEACFHCSQCRNSLVDKPFAAKEDQLLCTDCYSNEYSSKCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGTKSFIPKDNQNFCVPCYEKQHAMQCVQCKKPITTGGVTYREQPWHKECFVCTACRKQLSGQRFTARDDFAYCLNCFCDLYAKKCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLVGRGFLTERDDILCPDCGKDI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MTERFDCHH ------CCCCCCCCC | 35.55 | 19413330 | |
13 | Phosphorylation | DCHHCNESLFGKKYI CCCCCCHHHCCCEEE | 18.27 | 29214152 | |
17 | Ubiquitination | CNESLFGKKYILREE CCHHHCCCEEEECCC | 34.76 | - | |
17 | Acetylation | CNESLFGKKYILREE CCHHHCCCEEEECCC | 34.76 | 26051181 | |
27 | Phosphorylation | ILREESPYCVVCFET EECCCCCCEEEEEEE | 13.73 | - | |
56 | Phosphorylation | CDCKDLSYKDRHWHE CCCCCCCCCCCCHHH | 24.97 | - | |
57 | Acetylation | DCKDLSYKDRHWHEA CCCCCCCCCCCHHHH | 44.93 | 30588785 | |
74 | Phosphorylation | HCSQCRNSLVDKPFA HHHHHHHHHCCCCCC | 15.49 | 26657352 | |
78 | Acetylation | CRNSLVDKPFAAKED HHHHHCCCCCCCCCC | 34.26 | 26051181 | |
78 | Sumoylation | CRNSLVDKPFAAKED HHHHHCCCCCCCCCC | 34.26 | - | |
78 | Sumoylation | CRNSLVDKPFAAKED HHHHHCCCCCCCCCC | 34.26 | 25218447 | |
78 | Ubiquitination | CRNSLVDKPFAAKED HHHHHCCCCCCCCCC | 34.26 | - | |
83 | Acetylation | VDKPFAAKEDQLLCT CCCCCCCCCCEEEEE | 59.39 | 26051181 | |
83 | Malonylation | VDKPFAAKEDQLLCT CCCCCCCCCCEEEEE | 59.39 | 26320211 | |
87 (in isoform 2) | Phosphorylation | - | 7.02 | 23911959 | |
93 | Phosphorylation | QLLCTDCYSNEYSSK EEEEECCCCCCCHHH | 19.83 | 20562096 | |
97 | Phosphorylation | TDCYSNEYSSKCQEC ECCCCCCCHHHHHHH | 23.61 | - | |
100 | Ubiquitination | YSNEYSSKCQECKKT CCCCCHHHHHHHHCC | 33.72 | - | |
106 | Ubiquitination | SKCQECKKTIMPGTR HHHHHHHCCCCCCCC | 55.75 | - | |
107 | Phosphorylation | KCQECKKTIMPGTRK HHHHHHCCCCCCCCC | 14.17 | - | |
109 (in isoform 2) | Phosphorylation | - | 2.79 | 21712546 | |
111 (in isoform 2) | Phosphorylation | - | 22.29 | 21712546 | |
112 | Acetylation | KKTIMPGTRKMEYKG HCCCCCCCCCCEECC | 22.65 | - | |
112 | Phosphorylation | KKTIMPGTRKMEYKG HCCCCCCCCCCEECC | 22.65 | - | |
116 (in isoform 2) | Phosphorylation | - | 47.32 | 22199227 | |
118 (in isoform 2) | Phosphorylation | - | 38.72 | 22199227 | |
118 | Sumoylation | GTRKMEYKGSSWHET CCCCCEECCCCHHCE | 38.72 | - | |
118 | Malonylation | GTRKMEYKGSSWHET CCCCCEECCCCHHCE | 38.72 | 26320211 | |
118 | Sumoylation | GTRKMEYKGSSWHET CCCCCEECCCCHHCE | 38.72 | - | |
120 (in isoform 2) | Phosphorylation | - | 26.55 | 22199227 | |
120 | Phosphorylation | RKMEYKGSSWHETCF CCCEECCCCHHCEEE | 26.55 | 27251275 | |
121 | Phosphorylation | KMEYKGSSWHETCFI CCEECCCCHHCEEEE | 40.91 | 27251275 | |
121 (in isoform 2) | Phosphorylation | - | 40.91 | 22199227 | |
138 | Phosphorylation | RCQQPIGTKSFIPKD CCCCCCCCCCCCCCC | 25.00 | - | |
139 | Sumoylation | CQQPIGTKSFIPKDN CCCCCCCCCCCCCCC | 37.85 | - | |
139 | Ubiquitination | CQQPIGTKSFIPKDN CCCCCCCCCCCCCCC | 37.85 | - | |
139 | Sumoylation | CQQPIGTKSFIPKDN CCCCCCCCCCCCCCC | 37.85 | - | |
140 | Phosphorylation | QQPIGTKSFIPKDNQ CCCCCCCCCCCCCCC | 28.39 | - | |
144 | Ubiquitination | GTKSFIPKDNQNFCV CCCCCCCCCCCCEEE | 65.58 | - | |
144 | Sumoylation | GTKSFIPKDNQNFCV CCCCCCCCCCCCEEE | 65.58 | - | |
144 | Acetylation | GTKSFIPKDNQNFCV CCCCCCCCCCCCEEE | 65.58 | 26051181 | |
144 | Sumoylation | GTKSFIPKDNQNFCV CCCCCCCCCCCCEEE | 65.58 | - | |
144 | Malonylation | GTKSFIPKDNQNFCV CCCCCCCCCCCCEEE | 65.58 | 26320211 | |
154 | Phosphorylation | QNFCVPCYEKQHAMQ CCEEEECCCHHHHEE | 21.79 | 28152594 | |
156 | Ubiquitination | FCVPCYEKQHAMQCV EEEECCCHHHHEEHE | 22.40 | - | |
156 | Acetylation | FCVPCYEKQHAMQCV EEEECCCHHHHEEHE | 22.40 | 26051181 | |
160 | Sulfoxidation | CYEKQHAMQCVQCKK CCCHHHHEEHEECCC | 2.73 | 30846556 | |
166 | Ubiquitination | AMQCVQCKKPITTGG HEEHEECCCCCCCCC | 44.48 | - | |
167 | Ubiquitination | MQCVQCKKPITTGGV EEHEECCCCCCCCCC | 49.64 | - | |
167 | Sumoylation | MQCVQCKKPITTGGV EEHEECCCCCCCCCC | 49.64 | 25218447 | |
167 | Malonylation | MQCVQCKKPITTGGV EEHEECCCCCCCCCC | 49.64 | 26320211 | |
167 | Sumoylation | MQCVQCKKPITTGGV EEHEECCCCCCCCCC | 49.64 | - | |
170 | Phosphorylation | VQCKKPITTGGVTYR EECCCCCCCCCCEEC | 28.10 | 21406692 | |
171 | Phosphorylation | QCKKPITTGGVTYRE ECCCCCCCCCCEECC | 32.43 | 20068231 | |
175 | Phosphorylation | PITTGGVTYREQPWH CCCCCCCEECCCCCC | 21.82 | 20068231 | |
176 | Phosphorylation | ITTGGVTYREQPWHK CCCCCCEECCCCCCC | 15.11 | 20068231 | |
183 | Acetylation | YREQPWHKECFVCTA ECCCCCCCCEEEEHH | 52.92 | 26051181 | |
183 | Malonylation | YREQPWHKECFVCTA ECCCCCCCCEEEEHH | 52.92 | 26320211 | |
189 | Phosphorylation | HKECFVCTACRKQLS CCCEEEEHHHHHHHC | 24.40 | 27251275 | |
219 | Acetylation | CFCDLYAKKCAGCTN HHHHHHHHHHCCCCC | 34.52 | 26051181 | |
220 | Sumoylation | FCDLYAKKCAGCTNP HHHHHHHHHCCCCCC | 22.58 | 25218447 | |
220 | Sumoylation | FCDLYAKKCAGCTNP HHHHHHHHHCCCCCC | 22.58 | - | |
220 | Ubiquitination | FCDLYAKKCAGCTNP HHHHHHHHHCCCCCC | 22.58 | - | |
229 | Phosphorylation | AGCTNPISGLGGTKY CCCCCCCCCCCCCEE | 29.26 | 28555341 | |
234 | Phosphorylation | PISGLGGTKYISFEE CCCCCCCCEEEECCC | 20.90 | 28555341 | |
235 | Ubiquitination | ISGLGGTKYISFEER CCCCCCCEEEECCCE | 43.81 | - | |
235 | Acetylation | ISGLGGTKYISFEER CCCCCCCEEEECCCE | 43.81 | 26051181 | |
236 | Phosphorylation | SGLGGTKYISFEERQ CCCCCCEEEECCCEE | 11.13 | 23403867 | |
238 | Phosphorylation | LGGTKYISFEERQWH CCCCEEEECCCEECC | 24.42 | 30266825 | |
252 | Ubiquitination | HNDCFNCKKCSLSLV CCCCCCCCCCCEEEE | 58.90 | - | |
252 | Acetylation | HNDCFNCKKCSLSLV CCCCCCCCCCCEEEE | 58.90 | 26051181 | |
253 | Ubiquitination | NDCFNCKKCSLSLVG CCCCCCCCCCEEEEC | 31.12 | - | |
253 | Sumoylation | NDCFNCKKCSLSLVG CCCCCCCCCCEEEEC | 31.12 | - | |
253 | Sumoylation | NDCFNCKKCSLSLVG CCCCCCCCCCEEEEC | 31.12 | - | |
255 | Phosphorylation | CFNCKKCSLSLVGRG CCCCCCCCEEEECCC | 29.85 | 21406692 | |
257 | Phosphorylation | NCKKCSLSLVGRGFL CCCCCCEEEECCCCC | 12.52 | 21406692 | |
277 | Ubiquitination | ILCPDCGKDI----- CCCCCCCCCC----- | 59.59 | - | |
277 | Acetylation | ILCPDCGKDI----- CCCCCCCCCC----- | 59.59 | 30588779 | |
277 | Ubiquitination | ILCPDCGKDI----- CCCCCCCCCC----- | 59.59 | 21890473 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FHL2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FHL2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-238, AND MASSSPECTROMETRY. |